Literature DB >> 24493213

Long noncoding RNA in liver diseases.

Kenji Takahashi1, Irene Yan, Hiroaki Haga, Tushar Patel.   

Abstract

UNLABELLED: The identification of the presence of large RNA transcripts that do not code for proteins but that may have biological functions has provided an important new perspective in gene regulation. These long noncoding RNAs (lncRNAs) are being increasingly recognized to contribute to many biological processes through diverse mechanisms. The roles of these emerging genes are being recognized across kingdoms. These findings are profoundly altering our understanding of disease pathobiology and leading to the emergence of new biological concepts underlying human diseases. Strategies for the discovery and characterization of lncRNAs are highlighted. Several lncRNAs have been described in liver disease, and in liver cancers in particular. Their molecular mechanisms of action, function, and contributions to disease pathophysiology are reviewed. LncRNA genes associated with liver diseases have potential roles as biomarkers of disease diagnosis, prognosis, or therapeutic response as well as direct targets for therapeutic intervention.
CONCLUSION: The emerging knowledge in this rapidly advancing field offers promise for new fundamental knowledge and clinical applications that will be relevant for human liver diseases.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24493213      PMCID: PMC4110118          DOI: 10.1002/hep.27043

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  52 in total

1.  HELLP babies link a novel lincRNA to the trophoblast cell cycle.

Authors:  Marie van Dijk; Hari K Thulluru; Joyce Mulders; Omar J Michel; Ankie Poutsma; Sandra Windhorst; Gunilla Kleiverda; Daoud Sie; Augusta M A Lachmeijer; Cees B M Oudejans
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

2.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Ming-chun Lai; Zhe Yang; Lin Zhou; Qian-qian Zhu; Hai-yang Xie; Feng Zhang; Li-ming Wu; Lei-ming Chen; Shu-sen Zheng
Journal:  Med Oncol       Date:  2011-06-16       Impact factor: 3.064

3.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.

Authors:  Katrin Panzitt; Marisa M O Tschernatsch; Christian Guelly; Tarek Moustafa; Martin Stradner; Heimo M Strohmaier; Charles R Buck; Helmut Denk; Renée Schroeder; Michael Trauner; Kurt Zatloukal
Journal:  Gastroenterology       Date:  2006-08-14       Impact factor: 22.682

Review 4.  Non-coding RNAs as therapeutic targets in hepatocellular cancer.

Authors:  Chiara Braconi; Tushar Patel
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

5.  Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-catenin signaling.

Authors:  Dan Xu; Fu Yang; Ji-hang Yuan; Ling Zhang; Hai-shan Bi; Chuan-chuan Zhou; Feng Liu; Fang Wang; Shu-han Sun
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

6.  Activation of p53 by MEG3 non-coding RNA.

Authors:  Yunli Zhou; Ying Zhong; Yingying Wang; Xun Zhang; Dalia L Batista; Roger Gejman; Peter J Ansell; Jing Zhao; Catherine Weng; Anne Klibanski
Journal:  J Biol Chem       Date:  2007-06-13       Impact factor: 5.157

7.  Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR.

Authors:  Wing Pui Tsang; Timothy W L Wong; Albert H H Cheung; Chloe N N Co; Tim Tak Kwok
Journal:  RNA       Date:  2007-04-06       Impact factor: 4.942

8.  The transcriptional landscape of the mammalian genome.

Authors:  P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

9.  A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Yao Liu; Shandong Pan; Li Liu; Xiangjun Zhai; Jibin Liu; Juan Wen; Yixin Zhang; Jianguo Chen; Hongbing Shen; Zhibin Hu
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

10.  Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.

Authors:  Hui Xie; Hongwei Ma; Danqiu Zhou
Journal:  Biomed Res Int       Date:  2013-05-22       Impact factor: 3.411

View more
  92 in total

1.  The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.

Authors:  Hao-Long Qi; Chang-Sheng Li; Chong-Wei Qian; Yu-Sha Xiao; Yu-Feng Yuan; Quan-Yan Liu; Zhi-Su Liu
Journal:  Tumour Biol       Date:  2015-08-14

2.  Long non-coding RNA regulation of liver cancer stem cell self-renewal offers new therapeutic targeting opportunities.

Authors:  Mansi A Parasramka; Tushar Patel
Journal:  Stem Cell Investig       Date:  2016-01-18

3.  Protective vaccination alters gene expression of the liver of Balb/c mice in response to early prepatent blood-stage malaria of Plasmodium chabaudi.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2018-02-05       Impact factor: 2.289

4.  Expression levels of long non-coding RNA HOXA distal transcript antisense RNA and metabotropic glutamate receptor 1 in pancreatic carcinoma, and their prognostic values.

Authors:  Xiaoqing Wang; Lili Xiao; Haitao Yu
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

Review 5.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

6.  Discriminating cirRNAs from other lncRNAs using a hierarchical extreme learning machine (H-ELM) algorithm with feature selection.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; ShaoPeng Wang; Tao Huang; Yu-Dong Cai
Journal:  Mol Genet Genomics       Date:  2017-09-14       Impact factor: 3.291

7.  Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression.

Authors:  Ling Wei; Mengzhi Ling; Song Yang; Yunqian Xie; Changjiang Liu; Wenyi Yi
Journal:  Hum Cell       Date:  2021-01-02       Impact factor: 4.174

8.  Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.

Authors:  Li Zhang; Zhihong Yang; Jocelyn Trottier; Olivier Barbier; Li Wang
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

9.  Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation.

Authors:  Donghao Shang; Tie Zheng; Jian Zhang; Ye Tian; Yuting Liu
Journal:  Tumour Biol       Date:  2016-07-22

Review 10.  The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers.

Authors:  Chenhui Ma; Xuefei Shi; Qingqing Zhu; Qian Li; Yafang Liu; Yanwen Yao; Yong Song
Journal:  Tumour Biol       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.